← All trials
NCT04795557
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 19, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Jan 31, 2022
- First posted
- Mar 12, 2021
- Last posted
- Sep 21, 2021
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Swedish Herbal Institute ABLead sponsor
- Government of GeorgiaCollaborator
- Phytomed ABReponsible party - principal investigator
- Phytomed ABCollaborator
- Tbilisi State Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.